Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Carrington Laboratories
Recent developments from Carrington Laboratories outlined
April 11th, 2007
Recent developments from Carrington Laboratories outlined. This trend article is an immediate alert from NewsRx to identify the most recent news developments at Carrington Laboratories. Report 1: In view of a recent article in the January 16, 2007 Wall Street Journal about a "Permanent Threat" regarding the risk of an H5N1 (bird flu) pandemic and recent incidence of human cases in Vietnam and China, Carrington Laboratories, Inc., (CARN) issued a status report on DelSite Biotechnologies, Inc.'s influenza vaccine development. DelSite, a wholly-owned subsidiary of Carrington, has been developing a platform for the development...
Source: Medical Patent Law Weekly (2007-04-11)
|
